Companies: 10,795·Total market cap: $144.5T
GBS Inc.

GBS Inc.

GBSNASDAQHealthcare
$0.47
$-0.01(-1.58%)
Market Cap$433577
P/E Ratio
52W High$2.89
52W Low$0.36

GBS Inc. (GBS) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

gbs · pe ratio · data through Jun 30, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for GBS Inc. (GBS) measures how much investors pay for each dollar of the company's trailing earnings. GBS's current PE ratio of N/A is calculated by dividing its stock price of $0.47 by its TTM earnings per share of -$7.28.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-06-30

Forward P/E
N/A
EPS (TTM)
-$7.28
TTM · diluted EPS
PEG Ratio
-0.00
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · GBS Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-08

PE Ratio History

2018 – 2025 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Devices · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
GBS Inc.
GBS Inc.You
GBS
$0MN/A-$7.28
Biocept, Inc.
Biocept, Inc.
BIOC
$0MN/A-$56.78
BIOLASE, Inc.
BIOLASE, Inc.
BIOL
$1MN/A-$16.14
Leafly Holdings, Inc.
Leafly Holdings, Inc.
LFLY
$115MN/A-$2.30
ProSomnus, Inc.
ProSomnus, Inc.
OSA
$8MN/A-$1.49
Ontrak, Inc.
Ontrak, Inc.
OTRK
$2MN/A-$5.49
PAVmed Inc.
PAVmed Inc.
PAVM
$3M11.07x$0.60

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 8 of 8 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-06-30Latest
FY2025
$-2.00
2024-06-30
FY2024
$-6.10
2023-06-30
FY2023
$-10.58
2022-06-30
FY2022
$-0.57
2021-06-30
FY2021
$-0.52
2020-06-30
FY2020
$-0.28
2019-06-30
FY2019
$-0.65
2018-06-30
FY2018
$-0.44

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for GBS Inc. (GBS) measures how much investors pay for each dollar of the company's trailing earnings. GBS's current PE ratio of N/A is calculated by dividing its stock price of $0.47 by its TTM earnings per share of -$7.28.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.47 ÷ -$7.28 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

GBS pe ratio · 6 questions

GBS's current PE ratio is N/A as of 2026-06-08, based on a stock price of $0.47 and TTM EPS of -$7.28. Data sourced from Financial Modeling Prep via GBS's SEC 10-K and 10-Q filings.

GBS PE ratioWhat is GBS PE ratioCurrent PE ratio of GBSGBS PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · GBS Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08